Get the Stockscreener App
0.975
10.78%
0.0949
Pre-market:
.95
-0.025
-2.56%
Catheter Precision Inc. stock is traded at $0.975, with a volume of 179.24K.
It is up +10.78% in the last 24 hours and down -20.73% over the past month.
Catheter Precision, Inc. develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company was formerly known as Ra Medical Systems, Inc and changed its name to Catheter Precision, Inc. in August 2023. Catheter Precision, Inc. is based in Fort Mill, South Carolina.
See More
Previous Close:
$0.8801
Open:
$0.89
24h Volume:
179.24K
Relative Volume:
0.17
Market Cap:
$2.63M
Revenue:
$819.00K
Net Income/Loss:
$-17.70M
P/E Ratio:
-0.077
EPS:
-12.6647
Net Cash Flow:
$-8.45M
1W Performance:
-20.08%
1M Performance:
-20.73%
6M Performance:
-63.07%
1Y Performance:
-83.96%
1-Day Range:
$0.8874
$1.0499
1-Week Range:
$0.7906
$1.25
52-Week Range:
$0.7906
$15.68
Catheter Precision Inc. Stock (VTAK) Company Profile
Name
Catheter Precision Inc.
Sector
Industry
Phone
973 691 2000
Address
1670 Highway 160 West, Suite 205, Fort Mill
Compare VTAK vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTAK
Catheter Precision Inc.
|
0.975 | 2.37M | 819.00K | -17.70M | -8.45M | -12.66 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Catheter Precision Inc. Stock (VTAK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-19 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Nov-02-18 | Initiated | Maxim Group | Buy |
Catheter Precision Inc. Stock (VTAK) Latest News
FLYTE EMERGES AS DIRECT BENEFICIARY AS RISING FUEL COSTS DRIVE AIRLINE RETREAT FROM SHORT-HAUL ROUTES - GlobeNewswire Inc.
VTAK Definitive Agreement to Acquire 100% of Fly Flyte Inc. Obtains Shareholder Approval - 富途牛牛
VTAK to acquire Fly Flyte - Medical Buyer
Catheter Precision (VTAK) Gains Shareholder Approval for Acquisi - GuruFocus
Catheter Precision (VTAK) Gains Approval for Acquisition of Fly Flyte - GuruFocus
Catheter Precision (VTAK) Completes Acquisition of Fly Flyte - GuruFocus
VTAK adds FAA-certified jet operator, bringing in revenue now - Stock Titan
Catheter Precision, Inc. 8-K Filing: Approval of Common Stock Issuance for Preferred Stock Conversion (April 15, 2026) - Minichart
Catheter Precision stockholders approve share issuances and reverse split By Investing.com - Investing.com Canada
Catheter Precision stockholders approve share issuances and reverse split - Investing.com
Catheter Precision (NYSE: VTAK) records 49.5% shareholder turnout - Stock Titan
Trading Recap: Will Catheter Precision Inc stock benefit from M A2026 Volume Leaders & Safe Entry Zone Tips - baoquankhu1.vn
Catheter Precision Inc Announces Accepted Publication Of VIVO Clinical Evidence In EP Europace - marketscreener.com
Catheter Precision Announces Accepted Publication in Leading European Medical Journal - The Manila Times
31-patient heart study backs Catheter Precision mapping tool - Stock Titan
Breakout Move: Will Catheter Precision Inc benefit from green energy policies2026 Technical Overview & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
VTAK Should I Buy - Intellectia AI
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Buybacks Report: Will Catheter Precision Inc benefit from green energy policies2026 Geopolitical Influence & High Return Trade Opportunity Guides - baoquankhu1.vn
FOMO Trade: Is Catheter Precision Inc part of any ETF2026 Rallies & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Catheter Precision to Attend the Annual European Heart Rhythm Association Conference - The Manila Times
First large Europe event since LockeT CE Mark sends Catheter Precision to Paris - Stock Titan
Aug Outlook: Is Catheter Precision Inc stock undervalued right nowEarnings Risk Summary & High Accuracy Trade Alerts - baoquankhu1.vn
Wall Street Recap: Can Catheter Precision Inc deliver consistent EPS growth2026 Bull vs Bear & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
New LockeT Data Accepted in Leading Electrophysiology Journal - The Manila Times
A 139-patient heart-closure study puts Catheter Precision in a top journal - Stock Titan
Catheter Precision seeks buyer for cardiac device business By Investing.com - Investing.com Australia
Catheter Precision (VTAK) Seeks Buyer for Cardiac Electrophysiol - GuruFocus
Catheter Precision Inc engaged a strategic advisor to formally market for sale its cardiac electrophysiology business - marketscreener.com
Catheter Precision Engages Strategic Advisor - The Manila Times
Catheter Precision seeks buyer for cardiac device business - Investing.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - benzinga.com
Catheter Precision puts heart device business up for sale, pivots to aviation - Stock Titan
Catheter Precision reports net loss of USD 17.2M in 2025 - Medical Buyer
VTAK PE Ratio & Valuation, Is VTAK Overvalued - Intellectia AI
Catheter Precision reports 95% revenue increase, acquires aviation firm - Investing.com
Catheter Precision (NYSE: VTAK) posts 2025 loss, revenue up 95% and buys Flyte aviation unit - Stock Titan
Catheter Precision 2025 10-K: Revenue $0.82M, Net Loss $17.7M - TradingView
Catheter Precision: 2025 revenue rose to $819K, but a $17.2M net loss and urgent capital needs raise going concern risks - TradingView — Track All Markets
Catheter Precision, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Catheter Precision (NYSE: VTAK) flags going concern risk while expanding VIVO and LockeT - Stock Titan
Catheter Precision reports 95% revenue increase, acquires aviation firm By Investing.com - Investing.com Canada
Catheter Precision reports 2025 results and updates on strategic expansion - marketscreener.com
Catheter Precision Reports 2025 Results and Updates on Strategic Expansion - MarketScreener
Catheter Precision Reports 2025 Results And Updates On Strategic Expansion - TradingView
Catheter Precision (VTAK) CEO awarded 40,000 options at $1.15 exercise price - Stock Titan
Catheter Precision (VTAK) CFO awarded options for 40,000 shares at $1.15 - Stock Titan
Catheter Precision (VTAK) director receives 40,000 stock options at $1.15 strike - Stock Titan
Director James Caruso receives 40,000 VTAK options at $1.15 exercise price - Stock Titan
[Form 4] Catheter Precision, Inc. Insider Trading Activity - Stock Titan
Chart Watch: Can Catheter Precision Inc continue delivering strong returnsPortfolio Risk Report & Free Community Consensus Stock Picks - baoquankhu1.vn
Catheter Precision Inc. Stock (VTAK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.74%
1.72%
Cap:
|
Volume (24h):